Target intelligence / Profile preview

Zinc finger protein 408 (ZNF408)

Target
ZNF408
Molecular classification
Transcription factor (C2H2 zinc finger family), Chromatin-modifying protein (contains a predicted SET domain)
01

Overview

Zinc finger protein 408 (ZNF408) is a 720-amino acid transcription factor belonging to the C2H2 zinc finger family, characterized by 10 tandem C2H2-type zinc finger motifs essential for DNA binding[1][2][4][5]. It also contains a predicted SET domain implicated in protein–protein interactions that regulate chromatin structure and gene expression[1]. ZNF408 localizes primarily to the cell nucleus and plays critical roles in retinal vasculature development, as supported by animal model studies[1][3]. Mutations in ZNF408 have been causally linked to familial exudative vitreoretinopathy (FEVR), an inherited retinal vascular disease, and to a lesser extent, retinitis pigmentosa 72. In affected individuals, specific missense mutations can cause mislocalization of the protein and dominant-negative effects impairing protein function[1][5]. ZNF408 is not currently a direct drug target but serves as a disease gene and genetic biomarker for clinical diagnosis of FEVR.

Other names
ZNF408PFM14PRDM17FLJ12827EVR6RP72PR domain zinc finger protein 17PR/SET domain 17
02

Mechanism of action

Not applicable; ZNF408 is a transcription factor rather than a conventional pharmacological target. Mutations in ZNF408 may act in a dominant-negative fashion, disrupting normal protein localization and function

03

Biological functions

Transcriptional regulationRegulation of chromatin-mediated gene expressionRetinal vasculature developmentEmbryonic blood vessel developmentCellular differentiation (likely, by analogy to other zinc finger proteins)
04

Disease associations

Familial exudative vitreoretinopathy (FEVR), including autosomal dominant FEVRRetinitis pigmentosa 72 (RP72)
05

Safety considerations

No specific safety concerns or therapeutic challenges are described in drug development, as ZNF408 is not a drug target. However, haploinsufficiency or specific dominant-negative mutations disrupt vascular development and may have pleiotropic effects
06

Biomarkers

Mutations in ZNF408 (e.g., missense mutations at residues p.His455Tyr, p.Ser126Asn, p.Y418C, p.V261M, p.P634L) are genetic biomarkers for familial exudative vitreoretinopathy (FEVR) and related retinal vascular diseases

Beyond the preview

Go deeper on Zinc finger protein 408 (ZNF408).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 408 (ZNF408).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call